PEITC significantly reduced the levels of proinflammatory cytokines, such as TNF-α, IL-6, and IL-1β genes, in transcriptional levels and modulated ERK- and Akt-dependent and NF-κB signaling pathways in GBM 8401 cells. The gene discussed is IL1B; the disease is glioblastoma.